Acquisition by Vitoc Vlad of 123760 shares of MAIA Biotechnology subject to Rule 16b-3

About 56% of MAIA Biotechnology's investor base is looking to short. The analysis of overall sentiment of trading MAIA Biotechnology stock suggests that many investors are alarmed at this time. The current market sentiment, together with MAIA Biotechnology's historical and current headlines, can help investors time the market. In addition, many technical investors use MAIA Biotechnology stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Maia Biotechnology Inc director. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
MAIA insider trading alert for grant of stock options by Vitoc Vlad, Chief Executive Officer, on 2nd of June 2023. This event was filed by Maia Biotechnology Inc with SEC on 2023-06-05. Statement of changes in beneficial ownership - SEC Form 4

MAIA Biotechnology Fundamental Analysis

We analyze MAIA Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MAIA Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MAIA Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Retained Earnings

Retained Earnings Comparative Analysis

MAIA Biotechnology is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

MAIA Biotechnology Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MAIA Biotechnology stock to make a market-neutral strategy. Peer analysis of MAIA Biotechnology could also be used in its relative valuation, which is a method of valuing MAIA Biotechnology by comparing valuation metrics with similar companies.

Peers

MAIA Biotechnology Related Equities

DYAIDyadic International   10.73   
0%
100.0%
LYRALyra Therapeutics   5.56   
0%
51.0%
ARMPArmata Pharmaceuticals   4.46   
0%
41.0%
CSBRChampions Oncology   3.09   
0%
28.0%
GNLXGenelux Common   0.81   
0%
7.0%
TRGNFTransgene   0.00   
0%
0%
TLPPFTelix Pharmaceuticals   0.52   
4.0%
0%
CINGCingulate   0.83   
7.0%
0%
LRMRLarimar Therapeutics   1.00   
9.0%
0%
LCTXLineage Cell   1.96   
18.0%
0%
MNPRMonopar Therapeutics   3.20   
29.0%
0%
NAUTNautilus Biotechnology   4.49   
41.0%
0%
PRTGPortage Biotech   5.90   
54.0%
0%

Complementary Tools for MAIA Stock analysis

When running MAIA Biotechnology's price analysis, check to measure MAIA Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MAIA Biotechnology is operating at the current time. Most of MAIA Biotechnology's value examination focuses on studying past and present price action to predict the probability of MAIA Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MAIA Biotechnology's price. Additionally, you may evaluate how the addition of MAIA Biotechnology to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Share Portfolio
Track or share privately all of your investments from the convenience of any device